A novel mechanism that enables cells to maintain energy production even when their main power supply drops/fails has been ...
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Tisento Therapeutics has dosed the first subject in its Phase IIb PRIZM study, examining the effects of the oral ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...
Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...
In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...
The Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elamipretide for the treatment of Barth syndrome, a rare genetic disorder.
Researchers in India have developed a new nanoformulation that may improve the safety and efficacy of Parkinson's disease treatment, IANS, a partner ...